C. Bertolotto

发表

Microphthalmia-associated Transcription Factor Regulates RAB27A Gene Expression and Controls Melanosome Transport*

C. Chiaverini, Laurent Beuret, E. Flori, 2008, Journal of Biological Chemistry.

Involvement of FKHRL1 in melanoma cell survival and death

K. Bille, J. Ortonne, C. Bertolotto, 2008, Pigment cell & melanoma research.

Protein Kinase C θ and ε Promote T-cell Survival by a Rsk-dependent Phosphorylation and Inactivation of BAD*

C. Bertolotto, P. Auberger, N. Filippa, 2000, The Journal of Biological Chemistry.

PI3K mediates protection against TRAIL-induced apoptosis in primary human melanocytes

M. Khaled, R. Buscà, K. Bille, 2004, Cell Death and Differentiation.

Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny

P. Bahadoran, C. Bertolotto, R. Ballotti, 2011, Oncogene.

Secretome from senescent melanoma engages the STAT3 pathway to favor reprogramming of naive melanoma towards a tumor-initiating cell phenotype

V. Bonazzi, K. Bille, P. Bahadoran, 2013, Oncotarget.

Small but Challenging Conjunctival Melanoma: New Insights, Paradigms and Future Perspectives

C. Bertolotto, P. Hofman, S. Baillif, 2021, Cancers.

Inhibition of Patched Drug Efflux Increases Vemurafenib Effectiveness against Resistant BrafV600E Melanoma

D. Douguet, C. Bertolotto, V. Biou, 2020, Cancers.

Focus on cutaneous and uveal melanoma specificities

C. Bertolotto, R. Ballotti, G. Beranger, 2017, Genes & development.

Deregulated MITF sumoylation: A route to melanoma

C. Bertolotto, R. Ballotti, 2017, Molecular & cellular oncology.

Increased CD271 expression by the NF-kB pathway promotes melanoma cell survival and drives acquired resistance to BRAF inhibitor vemurafenib

P. Abbe, C. Bertolotto, R. Ballotti, 2015, Cell Discovery.

G li 2-Mediated Melanoma i nvasion and Metastasis

K. Hoek, C. Bertolotto, R. Ballotti, 2010 .

Liquid Biopsy for Solid Ophthalmic Malignancies: An Updated Review and Perspectives

C. Bertolotto, P. Hofman, B. Mograbi, 2020, Cancers.

Recent advances in understanding the role of HES6 in cancers

C. Bertolotto, R. Ballotti, P. Hofman, 2022, Theranostics.

IGF1 promotes resistance to apoptosis in melanoma cells through an increased expression of BCL2, BCL-X(L), and survivin.

K. Bille, J. Ortonne, C. Bertolotto, 2008, The Journal of investigative dermatology.

Apoptosis in Prostate Cancer Cells Metformin and 2-Deoxyglucose Induces p 53-Dependent Targeting Cancer Cell Metabolism : The Combination of

C. Bertolotto, I. Ben-Sahra, J. Tanti, 2010 .

In vitro and in vivo anti-melanoma effects of ciglitazone.

P. Bahadoran, J. Ortonne, C. Bertolotto, 2009, The Journal of investigative dermatology.

In Vitro and In Vivo Anti-Melanoma Effects of

J. Ortonne, C. Bertolotto, R. Ballotti, 2009 .

Fitting MITF regulation of PDE4D3 into the skin pigmentation puzzle

C. Bertolotto, R. Ballotti, Mickaël Ohanna, 2011, Pigment cell & melanoma research.

αMSH and Cyclic AMP Elevating Agents Control Melanosome pH through a Protein Kinase A-independent Mechanism

M. Khaled, Laurent Beuret, K. Bille, 2009, The Journal of Biological Chemistry.

Inhibition of the Phosphatidylinositol 3-Kinase/p70S6-Kinase Pathway Induces B16 Melanoma Cell Differentiation*

R. Buscà, J. Ortonne, C. Bertolotto, 1996, The Journal of Biological Chemistry.

New Targeted Therapies and Immunotherapies for Locally Advanced Periocular Malignant Tumours: Towards a New ‘Eye-Sparing’ Paradigm?

C. Bertolotto, G. Poissonnet, P. Hofman, 2021, Cancers.

E2F1 inhibition mediates cell death of metastatic melanoma

P. Abbe, C. Bertolotto, R. Ballotti, 2018, Cell Death & Disease.

Uncovering and deciphering the pro-invasive role of HACE1 in melanoma cells

C. Bertolotto, R. Ballotti, F. Reinier, 2018, Cell Death & Differentiation.

T and B leukemic cell lines exhibit different requirements for cell death: correlation between caspase activation, DFF40/DFF45 expression, DNA fragmentation and apoptosis in T cell lines but not in Burkitt's lymphoma

C. Bertolotto, P. Auberger, J. Ricci, 2002, Leukemia.

Inhibition of the Mitogen-activated Protein Kinase Pathway Triggers B16 Melanoma Cell Differentiation*

A. Brunet, R. Buscà, J. Ortonne, 1998, The Journal of Biological Chemistry.

Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo

P. Abbe, C. Bertolotto, R. Ballotti, 2019, Nature Communications.

Different cis-Acting Elements Are Involved in the Regulation of TRP1 and TRP2 Promoter Activities by Cyclic AMP: Pivotal Role of M Boxes (GTCATGTGCT) and of Microphthalmia

R. Buscà, P. Abbe, K. Bille, 1998, Molecular and Cellular Biology.

Tumor necrosis factor alpha-mediated inhibition of melanogenesis is dependent on nuclear factor kappa B activation

R. Buscà, P. Bahadoran, J. Ortonne, 1999, Oncogene.

Lysine Methyltransferase NSD1 and Cancers: Any Role in Melanoma?

C. Bertolotto, R. Ballotti, A. Aplin, 2022, Cancers.

NF1 loss induces senescence during human melanocyte differentiation in an iPSC‐based model

J. Utikal, C. Bertolotto, R. Ballotti, 2015, Pigment cell & melanoma research.

PGJ2 restores RA sensitivity in melanoma cells by decreasing PRAME and EZH2.

C. Bertolotto, R. Ballotti, S. Rocchi, 2014, Journal of dermatological science.

A Jurkat T cell variant resistant to death receptor-induced apoptosis. Correlation with heat shock protein (Hsp) 27 and 70 levels.

C. Bertolotto, P. Auberger, J. Ricci, 2001, European cytokine network.

Glycogen Synthase Kinase 3β Is Activated by cAMP and Plays an Active Role in the Regulation of Melanogenesis*

M. Khaled, K. Bille, J. Ortonne, 2002, The Journal of Biological Chemistry.

Microphthalmia Gene Product as a Signal Transducer in cAMP-Induced Differentiation of Melanocytes

D. Fisher, P. Abbe, K. Bille, 1998, The Journal of cell biology.

Orbital exenteration: an updated review with perspectives.

C. Bertolotto, G. Poissonnet, S. Baillif, 2021, Survey of ophthalmology.

Incidence of Orbital Exenteration: A Nationwide Study in France over the 2006-2017 Period

C. Bertolotto, S. Baillif, S. Lassalle, 2020, Ophthalmic epidemiology.

Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions

C. Bertolotto, P. Hofman, S. Lassalle, 2021, Cancers.

Translation of single-cell transcriptomic analysis of uveal melanomas to clinical oncology

C. Bertolotto, R. Ballotti, T. Strub, 2021, Progress in Retinal and Eye Research.

Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: implication of the microphthalmia gene product

K. Bille, J. Ortonne, C. Bertolotto, 1996, The Journal of cell biology.

BMP-2 stimulates tyrosinase gene expression and melanogenesis in differentiated melanocytes.

C. Bertolotto, R. Ballotti, O. Andrisani, 2001, Pigment cell research.

Fifteen‐year quest for microphthalmia‐associated transcription factor target genes

C. Bertolotto, R. Ballotti, Y. Cheli, 2010, Pigment cell & melanoma research.

Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma

C. Bertolotto, R. Ballotti, S. Gras, 2011, Oncogene.

Advances in melanoma senescence and potential clinical application

C. Bertolotto, R. Ballotti, Sandy Giuliano, 2011, Pigment cell & melanoma research.

GLI2 and M‐MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells

K. Hoek, C. Bertolotto, R. Ballotti, 2011, Pigment cell & melanoma research.

Involvement of Microphthalmia in the Inhibition of Melanocyte Lineage Differentiation and of Melanogenesis by Agouti Signal Protein*

D. Fisher, J. Ortonne, C. Bertolotto, 1998, The Journal of Biological Chemistry.

In B16 melanoma cells, the inhibition of melanogenesis by TPA results from PKC activation and diminution of microphthalmia binding to the M-box of the tyrosinase promoter

K. Bille, J. Ortonne, C. Bertolotto, 1998, Oncogene.

Microphthalmia associated transcription factor is a target of the phosphatidylinositol-3-kinase pathway.

M. Khaled, K. Bille, J. Ortonne, 2003, The Journal of investigative dermatology.

Preview : Published ahead of advance online publication Inhibition of Melanogenesis by the Antidiabetic Metformin

P. Abbe, C. Bertolotto, R. Ballotti, 2014 .

Regulatory and Functional Connection of Microphthalmia-Associated Transcription Factor and Anti-Metastatic Pigment Epithelium Derived Factor in Melanoma1

F. Rojo, C. Bertolotto, S. Zazo, 2014, Neoplasia.

Regulatory and Functional Connection of Microphthalmia

A. Sols, L. Peso, C. Bertolotto, 2014 .

Immune Checkpoints in Cancers: From Signaling to the Clinic

C. Bertolotto, R. Ballotti, Y. Cheli, 2021, Cancers.

The cleavage of microphthalmia-associated transcription factor, MITF, by caspases plays an essential role in melanocyte and melanoma cell apoptosis.

M. Khaled, K. Bille, J. Ortonne, 2005, Genes & development.

FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells

C. Bertolotto, R. Ballotti, D. Debayle, 2021, Cell Death & Differentiation.

REGULATION OF MELANOGENESIS BY THE AMINO-ACID TRANSPORTER SLC7A5.

K. Bille, C. Bertolotto, R. Ballotti, 2020, The Journal of investigative dermatology.

Up-regulation of MET Expression by α-Melanocyte-stimulating Hormone and MITF Allows Hepatocyte Growth Factor to Protect Melanocytes and Melanoma Cells from Apoptosis*

Laurent Beuret, E. Flori, R. Buscà, 2007, Journal of Biological Chemistry.

Hypoxia-inducible factor 1α is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells

M. Khaled, R. Buscà, K. Bille, 2005, The Journal of cell biology.

SOX9 is a key player in ultraviolet B-induced melanocyte differentiation and pigmentation

C. Bertolotto, R. Ballotti, V. Hearing, 2007, Proceedings of the National Academy of Sciences.

Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo

P. Abbe, C. Bertolotto, R. Ballotti, 2019, Nature Communications.

Melanoma: From Melanocyte to Genetic Alterations and Clinical Options

C. Bertolotto, 2013, Scientifica.

The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor?

C. Bertolotto, R. Ballotti, Y. Cheli, 2020, Molecular cancer.

Senescent cells develop a PARP-1 and nuclear factor-{kappa}B-associated secretome (PNAS).

K. Bille, C. Bertolotto, R. Ballotti, 2011, Genes & Development.

Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas.

Laurent Beuret, K. Bille, P. Bahadoran, 2010, Cancer research.

Lysosomal acid ceramidase ASAH1 controls the transition between invasive and proliferative phenotype in melanoma cells

K. Bille, P. Bahadoran, C. Bertolotto, 2018, Oncogene.

Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-Resistant Melanomas

J. Marine, C. Bertolotto, F. Rambow, 2018, Molecular Cancer Therapeutics.

Aurora B Is Regulated by the Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase (MAPK/ERK) Signaling Pathway and Is a Valuable Potential Target in Melanoma Cells*

K. Bille, P. Bahadoran, C. Bertolotto, 2012, The Journal of Biological Chemistry.

Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance.

P. Abbe, C. Bertolotto, R. Ballotti, 2016, Cancer cell.

Tumor-derived fibronectin is involved in melanoma cell invasion and regulated by V600E B-Raf signaling pathway.

P. Abbe, P. Bahadoran, J. Ortonne, 2007, The Journal of investigative dermatology.

ZEB1‐mediated melanoma cell plasticity enhances resistance to MAPK inhibitors

Marie Perier-Muzet, Maxime Battistella, Arnaud de la Fouchardière, 2016, EMBO molecular medicine.

Pathways from senescence to melanoma: focus on MITF sumoylation

C. Bertolotto, R. Ballotti, J. Leclerc, 2017, Oncogene.

SIRT1 promotes proliferation and inhibits the senescence-like phenotype in human melanoma cells

K. Bille, P. Bahadoran, C. Bertolotto, 2014, Oncotarget.

A germline oncogenic MITF mutation and tumor susceptibility.

C. Bertolotto, F. Lesueur, B. Paillerets, 2014, European journal of cell biology.

Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growth

J. Ortonne, C. Bertolotto, R. Ballotti, 2011, Cell Death and Differentiation.

Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner

P. Abbe, P. Bahadoran, C. Bertolotto, 2013, Molecular Cancer Therapeutics.

GLI2-mediated melanoma invasion and metastasis.

K. Hoek, C. Bertolotto, R. Ballotti, 2010, Journal of the National Cancer Institute.

Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells

P. Bahadoran, C. Bertolotto, R. Ballotti, 2012, Oncogene.

Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny

P. Bahadoran, C. Bertolotto, R. Ballotti, 2011, Oncogene.

A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

S. Puig, L. Thomas, S. Richard, 2011, Nature.

Melanoma models for the next generation of therapies.

L. Zon, R. White, C. Ceol, 2021, Cancer cell.

NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2

P. Bahadoran, C. Bertolotto, R. Ballotti, 2016, Oncogene.

Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells.

C. Bertolotto, I. Ben-Sahra, Y. Le Marchand-Brustel, 2010, Cancer research.

Metformin inhibits melanoma development through autophagy and apoptosis mechanisms

P. Bahadoran, C. Bertolotto, R. Ballotti, 2011, Cell Death and Disease.

Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression

K. Bille, C. Bertolotto, F. Luciani, 2017, Journal of the National Cancer Institute.

ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity

K. Bille, C. Bertolotto, R. Ballotti, 2021, Molecular cancer.

An Update on the Role of Ubiquitination in Melanoma Development and Therapies

C. Bertolotto, R. Ballotti, F. Soysouvanh, 2021, Journal of clinical medicine.

Signalling and chemosensitivity assays in melanoma: is mutated status a prerequisite for targeted therapy?

P. Bahadoran, J. Ortonne, C. Bertolotto, 2011, Experimental dermatology.

The “ART” of Epigenetics in Melanoma: From histone “Alterations, to Resistance and Therapies”

C. Bertolotto, R. Ballotti, T. Strub, 2020, Theranostics.

[MITF: a genetic key to melanoma and renal cell carcinoma?].

C. Bertolotto, F. Lesueur, B. Bressac- de Paillerets, 2012, Medecine sciences : M/S.

Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance.

P. Abbe, C. Bertolotto, R. Ballotti, 2016, Cancer cell.

MITF activity is regulated by a direct interaction with RAF proteins in melanoma cells

C. Bertolotto, A. Eychène, C. Pouponnot, 2022, Communications Biology.

MITF activity is regulated by a direct interaction with RAF proteins in melanoma cells

C. Bertolotto, A. Eychène, C. Pouponnot, 2022, Communications biology.

New level of regulation of MITF activity by direct interaction with RAF proteins

C. Bertolotto, A. Eychène, C. Pouponnot, 2021 .

Cutaneous and uveal melanoma: two different cancers in therapeutic needs.

C. Bertolotto, 2021, Comptes rendus biologies.

Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease

K. Bille, C. Bertolotto, R. Ballotti, 2021, Cell Death & Differentiation.

Single-cell RNA sequencing reveals intratumoral heterogeneity in 3 primary uveal melanomas and identi fi es HES 6 as a driver of the 4 metastatic disease

K. Bille, C. Bertolotto, R. Ballotti, 2021 .

CD271 is an imperfect marker for melanoma initiating cells

P. Bahadoran, C. Bertolotto, R. Ballotti, 2014, Oncotarget.

MCT-17-1141 289..300

J. Marine, C. Bertolotto, F. Rambow, 2019 .

Super-enhancer driven expression of BAHCC1 promotes melanoma cell proliferation and genome stability

C. Bertolotto, T. Ye, S. Le Gras, 2023, bioRxiv.

Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype

K. Bille, C. Bertolotto, R. Ballotti, 2018, Genes & development.

A new KIT mutation (N505I) in acral melanoma confers constitutive signaling, favors tumorigenic properties, and is sensitive to imatinib.

P. Bahadoran, C. Bertolotto, R. Ballotti, 2014, The Journal of investigative dermatology.

Cyclic AMP promotes a peripheral distribution of melanosomes and stimulates melanophilin/Slac2‐a and actin association

C. Chiaverini, R. Buscà, K. Bille, 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Differential requirements for ERK1/2 and P38 MAPK activation by thrombin in T cells. Role of P59Fyn and PKCε

C. Bertolotto, P. Auberger, M. Deckert, 2001, Oncogene.

Endoplasmic reticulum stress mediates resistance to BCL-2 inhibitor in uveal melanoma cells

C. Bertolotto, R. Ballotti, P. Gual, 2020, Cell Death Discovery.

BRCA1 is a new MITF target gene

Laurent Beuret, C. Bertolotto, R. Ballotti, 2011, Pigment Cell & Melanoma Research.

Thiopurine 6TG treatment increases tumor immunogenicity and response to immune checkpoint blockade

M. Nielsen, S. Buus, C. Bertolotto, 2022, Oncoimmunology.

FANCD2 functions as a critical factor downstream of MiTF to maintain the proliferation and survival of melanoma cells

C. Bertolotto, R. Ballotti, F. Rosselli, 2016, Scientific Reports.

Cleavage of the Serum Response Factor during Death Receptor-induced Apoptosis Results in an Inhibition of the c-FOS Promoter Transcriptional Activity*

C. Bertolotto, P. Auberger, J. Chambard, 2000, The Journal of Biological Chemistry.

Protein kinase C theta and epsilon promote T-cell survival by a rsk-dependent phosphorylation and inactivation of BAD.

C. Bertolotto, P. Auberger, N. Filippa, 2000, The Journal of biological chemistry.

Microphthalmia-Associated Transcription Factor (MITF) Regulates Immune Cell Migration into Melanoma

C. Bertolotto, R. Ballotti, S. Endres, 2018, Translational oncology.

Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) Biobank

C. Bertolotto, P. Hofman, B. Mograbi, 2023, Cancers.

Agroforestry in Umbria.

C. Bertolotto, F. Cannata, A. Pisanelli, 1995 .

Cholesterol efflux pathways hinder KRAS-driven lung tumor progenitor cell expansion.

C. Bertolotto, P. Barbry, B. Mari, 2023, Cell stem cell.

E2F1 inhibition mediates cell death of metastatic melanoma

P. Abbe, C. Bertolotto, R. Ballotti, 2018, Cell Death & Disease.

Uncovering and deciphering the pro-invasive role of HACE1 in melanoma cells

C. Bertolotto, R. Ballotti, F. Reinier, 2018, Cell Death & Differentiation.

MCT-12-1226-T 1605..1615

P. Abbe, P. Bahadoran, C. Bertolotto, 2013 .

Nicotinamide as a chemopreventive therapy of skin cancers. Too much of good thing?

C. Bertolotto, R. Ballotti, E. Healy, 2019, Pigment cell & melanoma research.

Assessment of Different Circulating Tumor Cell Platforms for Uveal Melanoma: Potential Impact for Future Routine Clinical Practice

C. Bertolotto, B. Mograbi, C. Bonnetaud, 2023, International journal of molecular sciences.

Functional role of MITF phosphorylation. In vivo veritas?

C. Bertolotto, R. Ballotti, 2009, Pigment cell & melanoma research.

Inhibition of Melanogenesis by the Antidiabetic

P. Abbe, C. Bertolotto, R. Ballotti, 2014 .

Corrigendum: A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

S. Puig, L. Thomas, S. Richard, 2015, Nature.

TFE3, a transcription factor homologous to microphthalmia, is a potential transcriptional activator of tyrosinase and TyrpI genes.

P. Abbe, K. Bille, C. Bertolotto, 2000, Molecular endocrinology.

Inhibition of Rho is required for cAMP-induced melanoma cell differentiation.

Shuh Narumiya, S. Narumiya, R. Buscà, 1998, Molecular biology of the cell.

Aurora B Is Regulated by the Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase (MAPK/ERK) Signaling Pathway and Is a Valuable Potential Target in Melanoma Cells*

K. Bille, P. Bahadoran, C. Bertolotto, 2012, The Journal of Biological Chemistry.

A germline oncogenic MITF mutation and tumor susceptibility.

C. Bertolotto, F. Lesueur, B. Paillerets, 2014, European journal of cell biology.

Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growth

C. Bertolotto, R. Ballotti, S. Rocchi, 2011, Cell Death and Differentiation.

Involvement of FKHRL1 in melanoma cell survival and death

K. Bille, C. Bertolotto, R. Ballotti, 2008, Pigment cell & melanoma research.

GLI2 and M‐MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells

K. Hoek, C. Bertolotto, R. Ballotti, 2011, Pigment cell & melanoma research.

Inhibition of melanogenesis by the antidiabetic metformin.

P. Abbe, C. Bertolotto, R. Ballotti, 2014, The Journal of investigative dermatology.

[Does orbital exenteration still has a place in 2019?]

C. Bertolotto, G. Poissonnet, A. Martel, 2019, Journal francais d'ophtalmologie.

NF1 loss induces senescence during human melanocyte differentiation in an iPSC‐based model

J. Utikal, C. Bertolotto, R. Ballotti, 2015, Pigment cell & melanoma research.

Metabolism under the spotlight in senescence

C. Bertolotto, 2014, Pigment cell & melanoma research.

CD271 is an imperfect marker for melanoma initiating cells

P. Bahadoran, C. Bertolotto, R. Ballotti, 2014, Oncotarget.